Year archive

Oculis Holding AG — 2024 filings

All 76 regulatory filings released by Oculis Holding AG (OCS) in 2024, sourced directly from the official regulator.

76 Filings

2024 Period

2024 filings (76)

Filing	Released	Lang
SC 13G Major Shareholding Notification	2024-12-10	English
Notification of managers transaction - Anthony Rosenberg - Dec 2024.pdf Director's Dealing	2024-12-06	English
Notification of managers transaction - Arshad Khanani - Dec 2024.pdf Director's Dealing	2024-12-06	English
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities Director's Dealing	2024-12-06	English
Oculis Publishes Notifications of T.. Director's Dealing	2024-12-06	English
6-K Foreign Filer Report	2024-11-29	English
Notification of managers transaction - Sylvia Cheung.pdf Director's Dealing	2024-11-29	English
Notification of managers transaction - Pall Johanesson.pdf Director's Dealing	2024-11-29	English
Notification of managers transaction - Anthony Rosenberg.pdf Director's Dealing	2024-11-29	English
Notification of managers transaction - Riad Sherif.pdf Director's Dealing	2024-11-29	English
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated Director's Dealing	2024-11-29	English
Oculis Publishes Notifications of T.. Director's Dealing	2024-11-29	English
Notification of managers transaction - Arshad Khanani - Nov 2024.pdf Director's Dealing	2024-11-27	English
Oculis Publishes Notification of Transaction by Person Discharging Managerial Responsibilities Director's Dealing	2024-11-27	English
Oculis Publishes Notification of Tr.. Remuneration Information	2024-11-27	English
Oculis to Present at the Stifel 2024 Healthcare Conference Regulatory Filings	2024-11-13	English
SC 13G/A Major Shareholding Notification	2024-11-07	English
6-K Foreign Filer Report	2024-11-07	English
Oculis birtir uppgjör fyrir þriðja ársfjórðung 2024 og kynnir nýjustu áfanga í rekstri félagsins Interim / Quarterly Report Q3 2024	2024-11-07	Icelandic
Oculis Reports Q3 2024 Financial Results and Provides Company Updates Earnings Release Q3 2024	2024-11-07	English
Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees Regulatory Filings	2024-10-21	English
Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer Board/Management Information	2024-10-02	English
Regulatory Filings 2024 Regulatory Filings	2024-09-09	English
424B3 Prospectus	2024-09-06	English
Regulatory Filings 2024 Regulatory Filings	2024-09-04	English
Regulatory Filings 2024 Regulatory Filings	2024-08-30	English
F-3 Regulatory Filings	2024-08-27	English
6-K Foreign Filer Report	2024-08-27	English
Oculis Q2 MDA.pdf Management Reports	2024-08-27	English
Oculis Q2 Unaudited Condensed Consolidated Interim Financial Statements.pdf Interim / Quarterly Report H1 2024	2024-08-27	English
Oculis Publishes Consolidated Q2 Financial Statements and MD&A Report Publication Announcement	2024-08-27	English
Oculis_Q2 2024 PR_Financial Schedules.xlsx Interim / Quarterly Report	2024-08-27	English
Oculis Q2 2024 earnings PR.pdf Earnings Release Q2 2024	2024-08-27	English
Oculis birtir uppgjör fyrir annan ársfjórðung 2024 og kynnir nýjustu áfanga í rekstri félagsins Earnings Release H1 2024	2024-08-27	Icelandic
Oculis Q2 2024 earnings PR.pdf Earnings Release Q2 2024	2024-08-27	English
Oculis_Q2 2024 PR_Financial Schedules.xlsx Interim / Quarterly Report	2024-08-27	English
Oculis Reports Q2 Financial Results and Provides Recent Company Update Earnings Release Q2 2024	2024-08-27	English
Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer Board/Management Information	2024-08-15	English
FORM 6-K Foreign Filer Report	2024-06-10	English
Oculis kynnir jákvæðar niðurstöður úr fasa 2b RELIEF-rannsókn með Licaminlimab, hannað til að umbylta meðferð augnþurrks með nákvæmnislyfjameðferð Earnings Release Q2 2024	2024-06-10	Icelandic
Oculis Announces Positive Topline Results of Phase 2b RELIEF Trial with Licaminlimab, Designed to Transform the Treatment Paradigm of Dry Eye Disease with a Precision Medicine Strategy Earnings Release Q2 2024	2024-06-10	English
Notification of managers transaction - Rosenberg - 2024 annual.pdf Director's Dealing	2024-06-04	English
Notification of managers transaction - Khanani - new director.pdf Director's Dealing	2024-06-04	English
Notification of managers transaction - Warner - new director.pdf Director's Dealing	2024-06-04	English
Notification of managers transaction - Ackermann - 2024 annual.pdf Director's Dealing	2024-06-04	English
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities Director's Dealing	2024-06-04	English
6-K Foreign Filer Report	2024-05-31	English
Oculis birtir niðurstöður aðalfundar 2024 og tilkynnir um skipanir í stjórn og vísindaráð AGM Information	2024-05-30	Icelandic
Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board AGM Information	2024-05-30	English
Oculis updates share capital for its existing at-the-market offering program Share Issue/Capital Change	2024-05-17	English
6-K Foreign Filer Report	2024-05-08	English
424B5 Prospectus	2024-05-08	English
6-K Foreign Filer Report	2024-05-08	English
Oculis Q1 Unaudited Condensed Consolidated Interim Financial Statements.pdf Interim / Quarterly Report Q1 2024	2024-05-08	English
Oculis Q1 MDA.pdf Management Reports	2024-05-08	English
Oculis Q1 2024 earning Press Release.pdf Earnings Release Q1 2024	2024-05-08	English
Oculis Reports Q1 2024 Financial Results and Provides Company Updates Earnings Release Q1 2024	2024-05-08	English
Oculis Publishes Invitation to the Annual General Meeting Report Publication Announcement	2024-05-07	English
6-K Foreign Filer Report	2024-04-29	English
6-K Foreign Filer Report	2024-04-22	English
424B5 Prospectus	2024-04-11	English
6-K Foreign Filer Report	2024-04-11	English
Regulatory Filings 2024 Regulatory Filings	2024-04-04	English
424B3 Prospectus	2024-04-03	English
Regulatory Filings 2024 Regulatory Filings	2024-04-03	English
Regulatory Filings 2024 Regulatory Filings	2024-04-01	English
Regulatory Filings 2024 Regulatory Filings	2024-04-01	English
F-3 Regulatory Filings	2024-04-01	English
POS AM Regulatory Filings	2024-04-01	English
20-F Annual Report FY 2023	2024-03-19	English
6-K Foreign Filer Report	2024-03-19	English
424B3 Prospectus	2024-02-28	English
6-K Foreign Filer Report	2024-02-28	English
SC 13G/A Major Shareholding Notification	2024-02-13	English
SC 13G/A Major Shareholding Notification	2024-02-13	English
SC 13G Major Shareholding Notification	2024-02-09	English